4 Winners in Marijuana Stocks

If your portfolio is not exposed to the cannabis industry in some shape or form, you're really missing out on something awesome! According to information from Investopedia and The Daily Marijuana Observer, there are some interesting finds in the marijuana space in recent weeks. Previously, we had discussed four stocks that would allow you to indirectly invest in this industry, and now here are four new names to keep on your radar -- these are NOT buy recommendations. Additional information on these stocks provided by Yahoo! Finance. All investing involves taking risk - do your research on these names before adding to your portfolio or seek the help of a financial adviser. I have provided advisory notes with each of these stocks.

Stony Hill Corp. (OTC:STNY)

With Stony Hill’s investment in High Times, it should be interesting to see what happens to share price when High Times goes public in the coming months. Stony Hill Corp., a vertically integrated company, focuses on various areas of the cannabis industry. The company explores the consumer, health and wellness, recreational, medical, media, nutraceutical, and cosmeceutical industries. It also operates vitacbd.com, which provides a line of cannabidiol (CBD) retail products, including CBD tinctures, ejuices, edibles, islates, salves, waxes, oils, and capsules, as well as related trade names, social media, accounts, and other related assets. In addition, the company licenses Damian Marley’s Stony Hill name. Further, it sells clothing, apparel, and other various branded products directly, as well as through its partners. The company is based in Beverly Hills, California. (NOTE: This company trades on the OTC market meaning that it is a penny stock. For more information on penny stocks and the risks associated with them, CLICK HERE.)

Marrone Bio Innovations Inc. (NASDAQ: MBII)

Back in August there were over 1 million shares of MBII being held short, and thanks to a recent, rapid increase in price per share it is likely that many bears are feeling the squeeze. Marrone provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. In addition, the company offers Haven, an anti-transpirant plant health product that reduces plant stress and dehydration; and Majestene, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, as well as reducing adult reproduction and egg hatch. The company was founded in 2006 and is headquartered in Davis, California. (NOTE: This company trades at under $10 per share meaning that it is a penny stock. For more information on penny stocks and the risks associated with them, CLICK HERE.)

Intec Pharma Ltd. (NASDAQ: NTEC)

Intec Pharma has been on quite a run recently, and was an obvious choice for one of the pot stock winners. On September 20th, NTEC announced that they would be participating in the Ladenburg Thalmann 2017 Healthcare Conference. Obviously this news helped push NTEC to a nice gain. Intec is a clinical stage biopharmaceutical company, and focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company’s lead product candidate is Accordion Pill Carbidopa/Levodopa (AP-CDLD), which is in a Phase III clinical trial for the treatment of Parkinson’s disease symptoms in advanced Parkinson’s disease patients. It is also developing pills for the treatment of insomnia, sleep maintenance, gastroduodenal, drug-induced ulcers, low back neuropethic pain, and fibromyalgia. Intec was founded in 2000 and is based in Jerusalem, Israel. (NOTE: This company trades at under $10 per share meaning that it is a penny stock. For more information on penny stocks and the risks associated with them, CLICK HERE.)

Atlantic Alliance Partnership Corp. (NASDAQ: AAPC)

In anticipation of an upcoming reverse merger with the cannabis REIT Kalyx Development Inc., Atlantic Alliance Partnership Corp., a blank check company, has been performing very well as of late. Atlantic Alliance Partnership Corp. does not have significant operations. It intends to acquire, engage in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchase all or substantially all of the assets of, or engage in any other similar initial business combination with one or more businesses or entities. The company was founded in 2015 and is based in New York, New York. (NOTE: This company has very low trading volume, and is therefore very high-risk. While it may have been a winner recently, that does not mean it will keep it up in the future. Better to watch for news as an indicator than investing directly.)

Featured Posts
Search By Tags
No tags yet.

© 2018 by Jennifer N. Coombs and GradMoney. Proudly created with Wix.com


All rights reserved. Use of this Site constitutes acceptance of our terms and conditions and privacy policy.


Restrictions: The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of GradMoney or Jennifer N. Coombs.


Disclaimer: All data and information provided on this site is strictly the author’s opinion and does not constitute any financial, legal or other type of advice. GradMoney, nor Jennifer N. Coombs, makes no representations as to accuracy, completeness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses or damages arising from its display or use. We also do not make any personal investments on behalf of readers, nor do we offer specific trading recommendations to readers. GradMoney is not a licensed broker dealer. All investment actions as a result of GradMoney’s articles are to be made at the discretion of the individual investor. All investments contain risks; GradMoney assumes no liability for any loss of income or principal.


All questions or inquiries my be directed to the attention of Jennifer N. Coombs.